arrow
M

Marc Yeste-Velasco

autonomous university of barcelona
H指数:20
被引数:1,242

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 Phase III study

Capivasertib 联合 Abiraterone 治疗 PTEN 缺失的转移性激素敏感性前列腺癌:CAPItello-281 III 期研究

2025-10-190
OAAI
A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer (vol 24, 876, 2024)
2024-07-290
OAAI
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
2024-07-223
OAAI
The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis
2020-09-179
OAAI
Phase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancer
2020-09-011
PREAI
The anticancer drug ABTL0812 induces cancer cell death by impairing Akt/mTORC1 axis and inducing ER stress-mediated cytotoxic autophagy
2020-08-150
PRE
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells
AUTOPHAGY
IF14.3
2020-05-2582
OAAI
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer
2020-02-0622
OAAI
Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer

前列腺癌转移相关基因FBXL4的鉴定

2017-07-1117
OAAI
Identification of ZDHHC14 as a novel human tumour suppressor gene

新的人类肿瘤抑制基因ZDHHC14的鉴定

2014-02-0849
OA